Tenet Healthcare Corp. (NYSE:THC) had its price objective decreased by Morgan Stanley from $15.00 to $14.00 in a research note published on Thursday. Morgan Stanley currently has an equal weight rating on the stock.

THC has been the subject of several other reports. Leerink Swann restated an outperform rating and issued a $30.00 price objective (up from $23.00) on shares of Tenet Healthcare Corp. in a report on Sunday, August 20th. Zacks Investment Research lowered shares of Tenet Healthcare Corp. from a hold rating to a strong sell rating in a report on Tuesday, September 19th. Royal Bank Of Canada restated a hold rating and issued a $25.00 price objective on shares of Tenet Healthcare Corp. in a report on Thursday, August 24th. Robert W. Baird restated a buy rating and issued a $23.00 price objective on shares of Tenet Healthcare Corp. in a report on Thursday, September 28th. Finally, Citigroup Inc. restated a hold rating and issued a $16.00 price objective on shares of Tenet Healthcare Corp. in a report on Thursday, September 14th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $19.14.

Shares of Tenet Healthcare Corp. (NYSE THC) traded up $0.32 on Thursday, reaching $13.82. 3,127,664 shares of the company’s stock traded hands, compared to its average volume of 3,678,225. The company has a quick ratio of 1.17, a current ratio of 1.28 and a debt-to-equity ratio of 21.21. Tenet Healthcare Corp. has a twelve month low of $12.25 and a twelve month high of $22.72.

Tenet Healthcare Corp. (NYSE:THC) last issued its quarterly earnings data on Monday, November 6th. The company reported ($0.17) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.40) by $0.23. Tenet Healthcare Corp. had a negative net margin of 6.28% and a negative return on equity of 739.56%. The business had revenue of $4.59 billion during the quarter, compared to analyst estimates of $4.94 billion. During the same period last year, the business posted $0.16 earnings per share. Tenet Healthcare Corp.’s quarterly revenue was down 5.4% compared to the same quarter last year. sell-side analysts predict that Tenet Healthcare Corp. will post 0.74 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/tenet-healthcare-corp-thc-price-target-cut-to-14-00-by-analysts-at-morgan-stanley/1694464.html.

Institutional investors and hedge funds have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA increased its position in shares of Tenet Healthcare Corp. by 34.6% during the second quarter. BNP Paribas Arbitrage SA now owns 66,690 shares of the company’s stock valued at $1,290,000 after acquiring an additional 17,151 shares in the last quarter. Private Management Group Inc. increased its position in shares of Tenet Healthcare Corp. by 1.2% during the second quarter. Private Management Group Inc. now owns 813,918 shares of the company’s stock valued at $15,741,000 after acquiring an additional 9,386 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Tenet Healthcare Corp. by 25.0% during the second quarter. Franklin Resources Inc. now owns 5,000,000 shares of the company’s stock valued at $96,700,000 after acquiring an additional 1,000,000 shares in the last quarter. Proxima Capital Management LLC increased its position in shares of Tenet Healthcare Corp. by 8.3% during the second quarter. Proxima Capital Management LLC now owns 103,939 shares of the company’s stock valued at $2,010,000 after acquiring an additional 8,000 shares in the last quarter. Finally, Legal & General Group Plc increased its position in shares of Tenet Healthcare Corp. by 5.6% during the second quarter. Legal & General Group Plc now owns 290,027 shares of the company’s stock valued at $5,610,000 after acquiring an additional 15,389 shares in the last quarter.

About Tenet Healthcare Corp.

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corp. (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.